Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Long term outcomes of ET and PV patients after clinical trial treatment with interferon alfa

Megan Metzger, Heidi Kosiorek, Ashley Yu, Veer Shah, Nooshin Beygui, Marina Kremyanskaya, Amylou Dueck, Ronald Hoffman, John Mascarenhas

Blood (2025) 146 (Supplement 1): 7345.

https://doi.org/10.1182/blood-2025-7345

Published: 2025

Journal Articles

A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1

Andrew Kuykendall, Rupali Roy, Abdulraheem Yacoub, Marina Kremyanskaya, Aaron Gerds, Ronald Paquette, Jeanne Palmer, Kathryn Johnson, Heidi Kosiorek, Amylou Dueck, Carolyn Mead-Harvey, Ashley Yu, Rami Komrokji, Raajit Rampal, Ruben Mesa, Ronald Hoffman, John Mascarenhas

Blood (2025) 146 (Supplement 1): 483.

https://doi.org/10.1182/blood-2025-483

Published: 2025

Journal Articles

Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial

Marina Kremyanskaya, Aaron Gerds, Rupali Bhave, Andrew Kuykendall, Eunice Wang, Heidi Kosiorek, Amylou Dueck, Carolyn Mead-Harvey, Kathryn Johnson, Ashley Yu, Anna Rita Migliaccio, Ruben Mesa, Ronald Hoffman, John Mascarenhas

Blood (2025) 146 (Supplement 1): 3829.

https://doi.org/10.1182/blood-2025-3829

Published: 2025

Journal Articles

Self-reported geriatric impairments and treatment toxicity in older patients with multiple myeloma - a single center prospective study

Blood (2025) 146 (Supplement 1): 715.

https://doi.org/10.1182/blood-2025-715

Published: 2025

Journal Articles

Bone marrow adipocytes (BMA) as a novel biomarker of molecular response in patients with essential thrombocythemia (ET) and polycythemia vera (PV) treated with pegylated interferon alfa-2A

John Mascarenhas, Justin Johnson, Heidi Kosiorek, Megan Metzger, Tiziano Barbui, Josef Prchal, Alessandro Rambaldi, Abdulraheem Yacoub, Ashley Yu, Ruben Mesa, Marina Kremyanskaya, Amylou Dueck, Ronald Hoffman, Mohamed Salama

Blood (2025) 146 (Supplement 1): 5590.

https://doi.org/10.1182/blood-2025-5590

Published: 2025

Journal Articles

Oral idasanutlin in patients with polycythemia vera

John Mascarenhas, Min Lu, Heidi Kosiorek, Elizabeth Virtgaym, Lijuan Xia, Lonette Sandy, Ruben Mesa, Bruce Petersen, Noushin Farnoud, Vesna Najfeld, Raajit Rampal, Amylou Dueck, Ronald Hoffman

Blood (2019) 134 (6): 525–533.

https://doi.org/10.1182/blood.2018893545

Published: 2019

Includes: Supplemental data

Journal Articles

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Leslie Padrnos, MD, Robyn M. Scherber, MD, Blake T. Langlais, Amylou Dueck, PhD, Jennifer Huberty, PhD, Holly L. Geyer, MD, Krisstina L. Gowin, DO, Heidi Kosiorek, MS, Marlene Bruso, MS, Zhenya Senyak, MA, Matthew M Clark, PhD, Michael Boxer, MD, Mary Cotter, MA, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2161.

https://doi.org/10.1182/blood.V130.Suppl_1.2161.2161

Published: 2017

Journal Articles

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Robyn M. Scherber, MD, Blake T. Langlais, Holly Geyer, MD, Amylou Dueck, PhD, Heidi Kosoriek, MS, Carol Johnston, PhD RD, Leslie Padrnos, MD, Jeanne Palmer, MD, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2193.

https://doi.org/10.1182/blood.V130.Suppl_1.2193.2193

Published: 2017

Journal Articles

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies

Raoul Tibes, MD PhD, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Jeanne Palmer, MD, James L. Slack, MD, Emily Ann Knight, NP, Saman Khalid Hashmi, MD, James M. Bogenberger, PhD, Darci Zblewski, CNP, William J. Hogan, MBBCh, Mark R. Litzow, MD, Ruben A Mesa, MD, James M. Foran, MD, Lisa Sproat, MD MSW, Aref Al-Kali, MD

Blood (2017) 130 (Supplement 1): 2629.

https://doi.org/10.1182/blood.V130.Suppl_1.2629.2629

Published: 2017

Journal Articles

Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia

John Mascarenhas, MD, Min Lu, PhDMD, Elizabeth Virtgaym, Heidi Kosiorek, MS, Marina Stal, Lonette Sandy, Alicia Orellana, MD MPH, Lijuan Xia, Marina Kremyanskaya, MD PhD, Bruce Petersen, MD, Amylou Dueck, PhD, Ronald Hoffman, MD

Blood (2017) 130 (Supplement 1): 254.

https://doi.org/10.1182/blood.V130.Suppl_1.254.254

Published: 2017

Journal Articles

Sleep and Psychiatric Disturbance in Chronic Philadelphia Negative Myeloproliferative Neoplasms

Krisstina L. Gowin, DO, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Denise Millstine, MD, Jennifer Huberty, PhD, Ryan Eckert, MS, Leslie Padrnos, MD, Robyn M. Scherber, MD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 4189.

https://doi.org/10.1182/blood.V130.Suppl_1.4189.4189

Published: 2017

Journal Articles

A Pilot Study of Online Yoga to Improve Fatigue and Quality of Life in Myeloproliferative Neoplasm Patients

Ryan Eckert, MS, Jennifer Huberty, PhD, Amylou Dueck, PhD, Heidi Kosiorek, MS, Linda Larkey, PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 3443.

https://doi.org/10.1182/blood.V130.Suppl_1.3443.3443

Published: 2017

Journal Articles

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Robyn M. Scherber, MD, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Holly Geyer, MD, Zhenya Senyak, Archie McCallister, MD, Mary Cotter, MA, Barbara VanHusen, Jeanne Palmer, MD, Leslie Padrnos, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 5657.

https://doi.org/10.1182/blood.V130.Suppl_1.5657.5657

Published: 2017

Journal Articles

The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs),

Robyn Scherber, MPH, Medical-Student, Amylou Dueck, PhD, Jean-Jacques Kiladjian, MD, PhD, Stephanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C. Schouten, MD, PhD, Federico Sackmann, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, PhD, Heike L. Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, Prof., Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD, PhD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, Jean-Yves Cahn, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti Radia, MD, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, Jan Samuelsson, MD, PhD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Ruben A. Mesa, MD

Blood (2011) 118 (21): 3839.

https://doi.org/10.1182/blood.V118.21.3839.3839

Published: 2011

Journal Articles

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): An International Prospective Validation Trial In 402 Patients

Robyn Scherber, MPH, Medical-Student, Amylou Dueck, PhD, Peter L. Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, Bjorn Andreasson, MD, PhD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, PhD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Claire N. Harrison, DM, Deepti Radia, Ruben A. Mesa, MD

Blood (2010) 116 (21): 4095.

https://doi.org/10.1182/blood.V116.21.4095.4095

Published: 2010

Journal Articles

Prospective Validation of the Swedish Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF: Swedish) In 114 MPN Patients

Peter L. Johansson, MD, PhD, Bjorn Andreasson, MD, Robyn Scherber, MPH, Medical-Student, Amylou Dueck, PhD, Jan Samuelsson, MD, PhD, Gunnar Birgegard, MD, PhD, Ayalew Tefferi, MD, Ruben A. Mesa, MD

Blood (2010) 116 (21): 5053.

https://doi.org/10.1182/blood.V116.21.5053.5053

Published: 2010

Journal Articles

Prospective Validation of the Italian Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF: Italian) In 186 MPN Patients

Robyn Scherber, MPH, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Giovanni Barosi, MD, Alessandro Rambaldi, MD, Maria L Ferarri, MD, Amylou Dueck, PhD, Ayalew Tefferi, MD, Ruben A. Mesa, MD

Blood (2010) 116 (21): 5060.

https://doi.org/10.1182/blood.V116.21.5060.5060

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Long term outcomes of ET and PV patients after clinical trial treatment with interferon alfa

A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1

Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial

Self-reported geriatric impairments and treatment toxicity in older patients with multiple myeloma - a single center prospective study

Bone marrow adipocytes (BMA) as a novel biomarker of molecular response in patients with essential thrombocythemia (ET) and polycythemia vera (PV) treated with pegylated interferon alfa-2A

Oral idasanutlin in patients with polycythemia vera

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies

Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia

Sleep and Psychiatric Disturbance in Chronic Philadelphia Negative Myeloproliferative Neoplasms

A Pilot Study of Online Yoga to Improve Fatigue and Quality of Life in Myeloproliferative Neoplasm Patients

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs),

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): An International Prospective Validation Trial In 402 Patients

Prospective Validation of the Swedish Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF: Swedish) In 114 MPN Patients

Prospective Validation of the Italian Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF: Italian) In 186 MPN Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only